Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03810742 |
|---|---|
| Brief Title: | Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors |
| First Submitted : | December 21, 2018 |
| First Submitted that Met QC Criteria : | January 17, 2019 |
| First Posted : | January 22, 2019 |
| Last Update Submitted that Met QC Criteria : | November 30, 2022 |
| Last Update Posted : | December 2, 2022 |